We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+15.89%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$280M
AUM Growth
+$20.1M
Cap. Flow
-$12.5M
Cap. Flow %
-4.46%
Top 10 Hldgs %
29.94%
Holding
74
New
13
Increased
17
Reduced
27
Closed
12

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$4.68M
2
ESRX
Express Scripts Holding Company
ESRX
+$3.86M
3
COR icon
Cencora
COR
+$3.68M
4
SYK icon
Stryker
SYK
+$3.41M
5
MOH icon
Molina Healthcare
MOH
+$3.19M

Sector Composition

Rank Sector Weight
1 Healthcare 91.22%
2 Financials 2.53%
3 Energy 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
$9.62M 3.43%
30,000
-586
-2% -$166K
BSX icon
2
Boston Scientific
BSX
$71.1B
$9.05M 3.23%
235,000
-25,000
-10% -$873K
BMY icon
3
Bristol-Myers Squibb
BMY
$134B
$8.69M 3.1%
140,000
+5,000
+4% +$297K
HUM icon
4
Humana
HUM
$45B
$8.56M 3.06%
25,300
+300
+1% +$97.5K
MRK icon
5
Merck
MRK
$316B
$8.51M 3.04%
125,760
+14,424
+13% +$919K
ABT icon
6
Abbott
ABT
$185B
$8.44M 3.01%
115,000
+20,000
+21% +$1.31M
CI icon
7
Cigna
CI
$74.5B
$8.33M 2.97%
40,000
+15,000
+60% +$2.78M
HCA icon
8
HCA Healthcare
HCA
$88B
$7.65M 2.73%
+55,000
New +$6.85M
ELV icon
9
Elevance Health
ELV
$83B
$7.54M 2.69%
27,500
+2,500
+10% +$649K
LLY icon
10
Eli Lilly
LLY
$995B
$7.51M 2.68%
70,000
-10,000
-13% -$1,000K
MOH icon
11
Molina Healthcare
MOH
$10.2B
$7.43M 2.65%
50,000
-25,000
-33% -$3.19M
AET
12
DELISTED
Aetna Inc
AET
$7.1M 2.53%
+35,000
New +$6.84M
UHS icon
13
Universal Health Services
UHS
$10.2B
$7.03M 2.51%
+55,000
New +$6.75M
ALGN icon
14
Align Technology
ALGN
$12.4B
$6.85M 2.44%
17,500
+4,500
+35% +$1.66M
VRTX icon
15
Vertex Pharmaceuticals
VRTX
$119B
$6.75M 2.41%
35,000
-8,600
-20% -$1.53M
UNH icon
16
UnitedHealth
UNH
$377B
$6.65M 2.37%
25,000
+4,427
+22% +$1.15M
CNC icon
17
Centene
CNC
$31.5B
$6.51M 2.33%
90,000
-22,200
-20% -$1.54M
BIO icon
18
Bio-Rad Laboratories Class A
BIO
$8.96B
$6.26M 2.23%
20,000
+2,500
+14% +$776K
BIIB icon
19
Biogen
BIIB
$29.8B
$6.18M 2.21%
17,500
-5,000
-22% -$1.72M
BAX icon
20
Baxter International
BAX
$14.5B
$6.17M 2.2%
80,000
ISRG icon
21
Intuitive Surgical
ISRG
$130B
$6.03M 2.15%
31,500
-6,000
-16% -$1.07M
ILMN icon
22
Illumina
ILMN
$29.9B
$5.51M 1.97%
15,420
BMRN icon
23
BioMarin Pharmaceuticals
BMRN
$11.6B
$5.33M 1.9%
55,000
-10,000
-15% -$998K
SYK icon
24
Stryker
SYK
$131B
$5.33M 1.9%
30,000
-20,000
-40% -$3.41M
ZBH icon
25
Zimmer Biomet
ZBH
$18.5B
$5.26M 1.88%
41,200

Similar funds

Sivik Global Healthcare's Q3 2018 Portfolio in Review

As of Q3 2018, Sivik Global Healthcare held 74 positions worth $280M, up 7.7% from $260M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Sivik Global Healthcare withdrew a net $12.5M in Q3 2018, closing 12 positions and reducing 27 holdings. Its most notable exit was Zoetis, an estimated $4.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 94% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in HCA Healthcare worth $7.65M.

  • Sivik Global Healthcare's largest Q3 2018 buy was HCA Healthcare: 55,000 shares worth $7.65M.
  • Sivik Global Healthcare added most to Cigna in Q3 2018, an estimated $2.78M increase.
  • Sivik Global Healthcare's biggest Q3 2018 reduction was Cencora, cutting an estimated $3.68M.
  • Sivik Global Healthcare fully exited Zoetis in Q3 2018, selling an estimated $4.68M.
  • Sivik Global Healthcare's ten largest holdings make up 30% of its $280M portfolio in Q3 2018.
  • Sivik Global Healthcare opened 13 new positions and closed 12 in Q3 2018.
  • Sivik Global Healthcare's portfolio value rose 7.7% quarter-over-quarter to $280M.

Based on Sivik Global Healthcare's 13F filing for Q3 2018, filed 13 Nov 2018.